'Anti hcv' diaporamas de présentation

?? C ???????? Current Status of Hepatitis C Treatment

?? C ???????? Current Status of Hepatitis C Treatment. ? ? ? Ming-Lung Yu Kaohsiung Municipal Ta-Tung Hospital Kaohsiung Medical University & Hospital Kaohsiung, Taiwan TSGH May 8, 2012. Outline. Introduction Evolution of Hepatitis C Treatment Standard-of-Care Personalized Therapy

957 views • 66 slides

University of Connecticut Health Center Bloodborne Pathogen Training

University of Connecticut Health Center Bloodborne Pathogen Training. You will now begin the Bloodborne Pathogen Refresher Training. The following program will review your occupational risks and the steps that you and the UCONN Health Center must take to reduce your risks of exposure.

742 views • 60 slides

MEDICAL GRANDROUNDS

659 views • 58 slides

Dr. Salwa Tayel & Prof. Ashry Gad Mohamed Depart. Family & Community Medicine

Epidemiology of Viral Hepatitis. Dr. Salwa Tayel & Prof. Ashry Gad Mohamed Depart. Family & Community Medicine College of Medicine October, 2015. Objectives. At the end of the lecture students should be able: Understand Classification of viral hepatitis.

698 views • 53 slides

Hepatitis C: An Overview

Hepatitis C: An Overview. Maria del Rosario, MD, MPH Division of Infectious Disease Epidemiology WVDHHR/BPH/OEPS August 2011. Objectives. At the conclusion of this talk, each participant should be able to: Discuss the epidemiology of Hepatitis C.

561 views • 42 slides

Epidemiology of drug use and Hepatitis C in New York City (and beyond)

Epidemiology of drug use and Hepatitis C in New York City (and beyond). Holly Hagan, PhD Director, Research Methods Core Center for Drug Use and HIV Research National Development and Research Institutes New York. What factors affect transmission of an infectious disease in a population?.

509 views • 38 slides

Hepatitis C

Hepatitis C. Prepared by Division of Viral Hepatitis Centers for Disease Control and Prevention. 1/17/03. Features of Hepatitis C Virus Infection. Incubation period Average 6-7 weeks Range 2-26 weeks Acute illness (jaundice) Mild ( < 20%) Case fatality rate Low Chronic infection 60%-85%

604 views • 37 slides

Hepatitis C Infection

Hepatitis C Infection

860 views • 34 slides

Hepatitis C- Global and National Perspective

Hepatitis C- Global and National Perspective. Dr Allister Grant Consultant Hepatologist University Hospitals Leicester NHS Trust. 20 Clear the HCV. 80 Develop Chronic Hepatitis. 20 No Harmful Effects. 60 Signs/symptoms. Age Gender Alcohol. 20% at 20yrs 50% at 30yrs. Liver Failure.

444 views • 32 slides

New drugs for HCV treatment in solid organ transplantation Xavier Forns Liver Unit

457 views • 30 slides

402 views • 26 slides

Epidemiology and prevention of HCV in IDUs

398 views • 25 slides

HIV/HCV co-infection in Taiwan

HIV/HCV co-infection in Taiwan. Nai-Ying Ko RN. PhD., Hsin-Chun Lee MD, Shainn-Wei Wang PhD., Wen-Chien Ko MD, National Cheng Kung University & Hospital Taiwan. Topics. Molecular epidemiology of HIV/HCV coinfection in Taiwan

608 views • 24 slides

Abstract

Factors associated to the prevalence of antibodies to hepatitis C virus in chronic hemodialysis patients in a sample of centers in Puerto Rico, 2005.

342 views • 23 slides

Hepatitis C

Hepatitis C. Prepared by Division of Viral Hepatitis Centers for Disease Control and Prevention Revised by Jill Gallin, CPNP Assistant Professor of Clinical Nursing Columbia University. 1/17/03. Features of Hepatitis C Virus Infection. Incubation period Average 6-7 weeks Range 2-26 weeks

693 views • 22 slides

Guidelines for Laboratory Testing and Result Reporting for Antibody to Hepatitis C Virus

Guidelines for Laboratory Testing and Result Reporting for Antibody to Hepatitis C Virus. BPAC September 18, 2003. Miriam J. Alter, Ph.D. Division of Viral Hepatitis Centers for Disease Control and Prevention. Working group Federal agencies CDC, FDA (CDRH, CBER) Professional associations

310 views • 21 slides

Routes of nosocomial transmission of HCV

Routes of nosocomial transmission of HCV. Valentina Liakina Centre of Hepatology, Gastroenterology and Dietetics Faculty of Medicine Vilnius University St. Petersburg, 2012-04-03. Topicality.

369 views • 20 slides

370 views • 17 slides

Laboratory of Plasma Derivatives Safety and Quality Control Section

Laboratory of Plasma Derivatives Safety and Quality Control Section. Principal Investigator: Mei-ying W. Yu, PhD. Research Projects. Safety and QC Standards Parvovirus B19 (5 studies)

223 views • 7 slides

Fig. 1, Lambotin et al.

p=0.023. n.s. n.s. A. BDCA2. CD11c. IL-3R. CD80. CD86. pDCs. mDCs. B. CD81. SR-BI. CLDN1. DC-SIGN. pDCs. mDCs. C. Fig. 1, Lambotin et al. 10 7. 10 7. 10 6. 10 6. 10 5. 10 5. 10 4. 10 4. 10 3. 10 3. 10 2. 10 2. 10 1. 10 1. 10 0. 10 0. NC. NC. rat IgG. rat IgG.

136 views • 3 slides